Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Bell

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Research|February 1, 1993
Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cellsG J Smith, W N Bell, J W Grisham
In Vitro|June 1, 1978
Differing effects of isoleucine deficiency on the toxicity of MNNG for 10T1/2 and CHO cellsD S Greenberg, J W Grisham, W N Bell, et al.
Neurosurgery|October 1, 1990
Spinal cord thromboplastin-induced coagulopathy in a rabbit modelJ V Pattisapu, J D Miller, W N Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Research|February 1, 1993
Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cellsG J Smith, W N Bell, J W Grisham
In Vitro|June 1, 1978
Differing effects of isoleucine deficiency on the toxicity of MNNG for 10T1/2 and CHO cellsD S Greenberg, J W Grisham, W N Bell, et al.
Neurosurgery|October 1, 1990
Spinal cord thromboplastin-induced coagulopathy in a rabbit modelJ V Pattisapu, J D Miller, W N Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.
Pageof 1